AKTX · Insider Trading
Akari Therapeutics plc ADR (0.01 USD)
Every open-market purchase and sale reported by AKTX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-16 | Robert B Bazemore | Director | MIXED | +21,643 | +$140.42K |
| 2026-10-16 | Samir Rashmikant Patel | Director | A | +8,536 | +$67.43K |
| 2026-10-16 | Abizer Gaslightwala | CEO | M | +27,066 | +$11 |
| 2026-10-16 | Hoyoung Huh | Director | A | +23,409 | +$184.91K |
| 2026-10-16 | Raymond Prudo-Chlebosz | Director | A | +12,312 | +$97.25K |
| 2026-10-16 | Sandip I Patel | Director | MIXED | +26,465 | +$129.65K |
| 2026-10-14 | Vatnak Vat-Ho | Chief Business Officer | A | +87,000 deriv. | — |
| 2026-10-01 | Abizer Gaslightwala | CEO | A | +6,430 | +$62.50K |
| 2026-08-19 | Kameel D. Farag | Interim CFO | A | +1,728 | +$12.99K |
| 2026-08-05 | Kameel D. Farag | Interim CFO | A | +1,130 | +$12.99K |
| 2026-07-17 | Samir Rashmikant Patel | Director | M | +22,474 | +$9.68K |
| 2026-06-25 | Abizer Gaslightwala | CEO | A | +21,063 deriv. | — |
| 2026-06-25 | Kameel D. Farag | Interim CFO | A | +18,830 | +$105.01K |
| 2026-03-16 | James R Neal | Director | Buy | +11,132 deriv. | — |
| 2025-12-18 | Samir Rashmikant Patel | Director | Buy | +1,701,310 deriv. | — |
| 2025-12-18 | Raymond Prudo-Chlebosz | Director | Buy | +2,010,638 deriv. | — |
| 2025-12-18 | Sandip I Patel | Director | Buy | +804,252 deriv. | — |
| 2025-12-18 | Abizer Gaslightwala | CEO | Buy | +2,165,302 deriv. | — |
| 2025-12-18 | Hoyoung Huh | Director | Buy | +7,423,902 deriv. | — |
| 2025-12-18 | Robert B Bazemore | Director | Buy | +309,326 deriv. | — |
| 2025-12-18 | Kameel D. Farag | Interim CFO | Buy | +49,490 deriv. | — |
| 2025-11-04 | Kameel D. Farag | Interim CFO | A | +58,619 | +$43.96K |
| 2025-10-24 | Kameel D. Farag | Interim CFO | A | +6,277 | +$4.64K |
| 2025-08-29 | Abizer Gaslightwala | CEO | Buy | +21,000 | +$19.54K |
| 2025-06-25 | Abizer Gaslightwala | President & CEO | Buy | +6,146 | +$7.12K |
| 2025-06-24 | Abizer Gaslightwala | President & CEO | Buy | +10,000 | +$12.00K |
| 2025-06-20 | Abizer Gaslightwala | President & CEO | Buy | +15,000 | +$18.00K |
| 2025-06-16 | Abizer Gaslightwala | CEO | A | +45,000 | +$54.35K |
| 2025-06-12 | Abizer Gaslightwala | CEO | A | +20,000 | +$25.40K |
| 2025-04-29 | Sandip I Patel | Director | A | +44,642 | +$50.00K |
| 2025-03-24 | Abizer Gaslightwala | Director | A | — | — |
| 2025-03-24 | Raymond Prudo-Chlebosz | Director | A | — | — |
| 2025-03-24 | Torsten Hombeck | CFO | A | — | — |
| 2025-03-24 | Samir Rashmikant Patel | Director | A | — | — |
| 2025-03-24 | Robert B Bazemore | Director | A | — | — |
| 2025-03-24 | Sandip I Patel | Director | A | — | — |
| 2025-03-24 | Hoyoung Huh | Director | A | — | — |
| 2025-03-24 | James R Neal | Director | A | — | — |
| 2025-03-10 | James R Neal | Director | A | +4,464 | +$5.00K |
| 2025-03-10 | Robert B Bazemore | Director | A | +44,642 | +$50.00K |
| 2025-03-10 | Samir Rashmikant Patel | Director | A | +406,250 | +$455.00K |
| 2025-03-10 | Hoyoung Huh | Director | A | +892,857 | +$1000.00K |
| 2025-03-10 | Raymond Prudo-Chlebosz | Director | A | +446,428 | +$500.00K |
| 2025-03-10 | Abizer Gaslightwala | Director | A | +133,928 | +$150.00K |
| 2025-02-07 | Abizer Gaslightwala | Director | A | +11,640 | +$14.20K |
| 2025-01-13 | Torsten Hombeck | CFO | A | +200 | +$244 |
| 2025-01-13 | Abizer Gaslightwala | Director | A | +11,439 | +$13.96K |
| 2025-01-10 | James R Neal | Director | A | +8,000,000 | +$4.80K |
| 2025-01-07 | Abizer Gaslightwala | Director | A | +1,720,000 | +$1.03K |
| 2025-01-07 | Samir Rashmikant Patel | Director | A | +208,000 | +$125 |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Hoyoung Huh | Director | 143,541 | $1.10M |
| Samir Rashmikant Patel | Director | 89,078 | $679.67K |
| Raymond Prudo-Chlebosz | Director | 86,871 | $662.83K |
| Sandip I Patel | Director | 39,033 | $297.82K |
| Abizer Gaslightwala | CEO | 33,440 | $255.15K |
| Kameel D. Farag | Interim CFO | 23,309 | $177.85K |
| Robert B Bazemore | Director | 22,759 | $173.65K |
| James R Neal | Director | 907 | $6.92K |
| Torsten Hombeck | CFO | 5 | $38 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AKTX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.